Empowered Funds’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Empowered Funds's PCRX Position: Q3 2026 in Review
Empowered Funds increased its Pacira BioSciences (PCRX) stake by 31% in Q3 2026, buying an estimated $1.57M and bringing the position to 262,102 shares worth $6.57M. The position accounts for 0.03% of the portfolio, ranked #634.
Empowered Funds first reported a position in PCRX in Q3 2024 and has held it in 8 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Empowered Funds held 262,102 shares of Pacira BioSciences worth $6.57M as of Q3 2026.
- Empowered Funds bought 62,029 Pacira BioSciences shares in Q3 2026, an estimated $1.57M.
- Pacira BioSciences made up 0.03% of Empowered Funds's portfolio in Q3 2026, its #634 holding.
- Empowered Funds first reported a position in Pacira BioSciences in Q3 2024 and has held it in 8 quarters since.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.